NYSE:NUS - Nu Skin Enterprises Stock Price, News & Analysis

+0.52 (+1.18 %)
(As of 09/16/2019 04:00 PM ET)
Today's Range
Now: $44.54
50-Day Range
MA: $40.89
52-Week Range
Now: $44.54
Volume377,300 shs
Average Volume679,522 shs
Market Capitalization$2.47 billion
P/E Ratio12.65
Dividend Yield3.36%
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products. Read More…

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples



Sales & Book Value

Annual Sales$2.68 billion
Cash Flow$5.1137 per share
Book Value$14.11 per share


Net Income$121.88 million


Market Cap$2.47 billion
Next Earnings Date11/6/2019 (Estimated)

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Tuesday, August 6th. Investors of record on Friday, August 30th will be given a dividend of $0.37 per share on Wednesday, September 11th. This represents a $1.48 annualized dividend and a yield of 3.32%. The ex-dividend date is Thursday, August 29th. View Nu Skin Enterprises' Dividend History.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings data on Tuesday, August, 6th. The company reported $0.83 earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of $0.83. The firm had revenue of $623.50 million for the quarter, compared to analysts' expectations of $622.32 million. Nu Skin Enterprises had a return on equity of 24.73% and a net margin of 4.79%. The business's revenue was down 11.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.95 EPS. View Nu Skin Enterprises' Earnings History.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Nu Skin Enterprises.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its FY19 earnings guidance on Tuesday, August, 6th. The company provided EPS guidance of $3.20-$3.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.30. The company issued revenue guidance of $2.48-$2.52 billion, compared to the consensus revenue estimate of $2.51 billion.

What price target have analysts set for NUS?

8 Wall Street analysts have issued 12-month target prices for Nu Skin Enterprises' shares. Their forecasts range from $39.00 to $70.00. On average, they expect Nu Skin Enterprises' share price to reach $50.7143 in the next year. This suggests a possible upside of 13.9% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.

What is the consensus analysts' recommendation for Nu Skin Enterprises?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 sell ratings, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nu Skin Enterprises.

What are Wall Street analysts saying about Nu Skin Enterprises stock?

Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
  • 1. Pivotal Research analysts commented, "We suspect that NUS management has taken an axe to the outlook to avoid having to cut again." (8/7/2019)
  • 2. According to Zacks Investment Research, "Nu Skin, which has outdone the industry in the past month, has been steadily gaining from solid performance across most regional units and sustained growth in customer count. These upsides and enhanced margins fueled first-quarter 2019 results, wherein top and bottom lines grew year over year and surpassed estimates. Further, the company’s focus on expanding global beauty device systems and optimizing the Velocity program bodes well. This is reflected in management’s outlook for 2019. However, the company issued a soft view for the second quarter, which is likely to be hurt by tough year-over-year comparisons related to LumiSpa. Moreover, currency headwinds are expected to persist, and hurt sales growth by 4-5% and 2-3% in the second quarter and 2019, respectively. Competition from cheaper alternatives is certainly a threat as well." (5/3/2019)

Has Nu Skin Enterprises been receiving favorable news coverage?

Media headlines about NUS stock have trended somewhat positive on Monday, InfoTrie reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nu Skin Enterprises earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Nu Skin Enterprises.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,336,500 shares, a decline of 33.2% from the July 15th total of 2,001,400 shares. Based on an average daily trading volume, of 650,500 shares, the days-to-cover ratio is currently 2.1 days. Approximately 2.6% of the shares of the company are sold short. View Nu Skin Enterprises' Current Options Chain.

Who are some of Nu Skin Enterprises' key competitors?

Some companies that are related to Nu Skin Enterprises include Herbalife Nutrition (HLF), PetIQ (PETQ), Trxade Group (TRXD), biOasis Technologies (BIOAF) and Aceto (ACET).

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Herbalife Nutrition (HLF), Marathon Petroleum (MPC), Baidu (BIDU), Alphabet (GOOG), Netflix (NFLX), Mastercard (MA), Booking (BKNG) and Tesla (TSLA).

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the folowing people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 66)
  • Mr. Ritch N. Wood, CEO & Director (Age 53)
  • Mr. Ryan S. Napierski, Pres (Age 45)
  • Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66)

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.57%), BlackRock Inc. (11.59%), Vanguard Group Inc. (10.59%), Renaissance Technologies LLC (2.66%), D. E. Shaw & Co. Inc. (2.18%) and AQR Capital Management LLC (1.81%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

Which major investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., BlackRock Inc., Morgan Stanley, Vanguard Group Inc., Acadian Asset Management LLC, Prescott Group Capital Management L.L.C., Canada Pension Plan Investment Board and Panagora Asset Management Inc.. View Insider Buying and Selling for Nu Skin Enterprises.

Which major investors are buying Nu Skin Enterprises stock?

NUS stock was purchased by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., Invesco Ltd., Natixis, Natixis, Renaissance Technologies LLC, Wasatch Advisors Inc., Delek Group Ltd. and First Trust Advisors LP. View Insider Buying and Selling for Nu Skin Enterprises.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $44.54.

How big of a company is Nu Skin Enterprises?

Nu Skin Enterprises has a market capitalization of $2.47 billion and generates $2.68 billion in revenue each year. The company earns $121.88 million in net income (profit) each year or $3.52 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.View Additional Information About Nu Skin Enterprises.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is http://www.nuskinenterprises.com/.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]

MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  453 (Vote Outperform)
Underperform Votes:  418 (Vote Underperform)
Total Votes:  871
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel